Family Safety Net - Aim 3: Randomized Control Trial
Launched by UNIVERSITY OF MICHIGAN · Dec 9, 2022
Trial Information
Current as of November 08, 2025
Active, not recruiting
Keywords
ClinConnect Summary
The Family Safety Net trial is studying how effective two different types of counseling sessions can be in improving home safety, especially around firearms and medications, in families living in Northwest Alaska. The main goal is to see if these sessions can help families store guns safely (unloaded and locked) and keep dangerous medications secured, which can reduce the risk of suicide and accidental injuries. Participants will answer questions about their mental health concerns and, based on their answers, will be placed in one of four groups to receive either motivational counseling, scripted safety talks, or general gun safety information.
To be eligible for the trial, participants need to be adults over 18 years old, live in the area, understand English, have a gun in their home, and have a phone that can receive text messages. Those selected for the study will receive helpful materials like trigger locks and medication boxes, as well as support through text messages for four weeks. After a month, they will complete a follow-up survey to see how they’ve implemented what they learned and share their thoughts on the program. This trial aims to create a safer environment for families by providing resources and support for responsible gun and medication storage.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- * Adults (over 18) who:
- • lives in the region,
- • Read and Understand English,
- • Live in a household with at least one gun,
- • Have a phone that can receive texts,
- • Lives in a household where young people (under 29) spend time
- Exclusion Criteria:
- • Someone else in the household has already participated in the study
About University Of Michigan
The University of Michigan, a leading academic institution renowned for its commitment to advancing healthcare and medical research, serves as a prominent clinical trial sponsor. With a robust infrastructure that supports innovative research initiatives, the university leverages its multidisciplinary expertise to conduct a wide array of clinical trials aimed at improving patient outcomes and advancing medical knowledge. Through its state-of-the-art facilities and collaborative environment, the University of Michigan fosters partnerships between researchers, clinicians, and industry leaders, ensuring the development of cutting-edge therapies and interventions that address pressing health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kotzebue, Alaska, United States
Patients applied
Trial Officials
Lisa M Wexler, PhD, MSW
Principal Investigator
University of Michigan
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials